INTRODUCTION
============

After the influenza A H1N1 epidemics, the use of extracorporeal membrane oxygenation (ECMO) has increased worldwide. The goal of respiratory ECMO support is to improve hypoxemia and hypercapnia, allowing protective mechanical ventilation to avoid further ventilator-associated lung injury ([@b1-cln_67p1511]). The current literature supports improved outcomes using ECMO in severe lung injury patients. In Brazil, few hospitals are able to provide respiratory ECMO support, and there is no transfer system ([@b2-cln_67p1511]).

The aim of this manuscript was to present and discuss two cases of severe respiratory failure supported with ECMO.

CASE DESCRIPTION 1
==================

A previously healthy 27-year-old man was admitted to a tertiary hospital in Guarulhos, São Paulo, with a diagnosis of severe community-acquired pneumonia. Three days later, his clinical status deteriorated, and mechanical ventilation was initiated due to severe hypoxemic respiratory failure. Prone positioning and alveolar recruitment were attempted without success. Pneumothorax with a bronchopleural fistula complicated the clinical status, and the ECMO team from Hospital das Clínicas, São Paulo, Brazil, was called. A team consisting of one physician, one intensive care fellow, one registered respiratory therapist, and one registered nurse was sent to assess the patient. During the evaluation, the patient was found to have sustained pulse oximetry of 52%, an arterial partial pressure of oxygen (PaO~2~) of 43 mmHg and an arterial partial pressure of CO~2~ (PaCO~2~) of 142 mmHg, with an inspired fraction of oxygen (FiO~2~) of 1 and optimized mechanical ventilation. There were no signs of hemodynamic compromise. Venous-venous ECMO support was initiated. The initial parameters were set at an oxygen flow (sweeper) of 6 L/min and a blood flow of 6 L/min. Ventilation was adjusted to pressure control mode, with a peak inspiratory pressure of 20 cmH~2~O, a positive end-expiratory pressure of 10 cmH~2~O, a respiratory rate of 10 breaths per minute and an FiO~2~ of 0.3. After stabilization, the patient was transferred to Hospital das Clínicas 27 km away in an ICU ambulance transport. The entire process, from initial call to arrival at Hospital das Clínicas, lasted 10 hours. The clinical and arterial blood gas data during the ICU stay are shown in [Table 1](#t1-cln_67p1511){ref-type="table"}. A chest radiograph is shown in [Figure 1a](#f1-cln_67p1511){ref-type="fig"}.

Twenty-four hours after arrival at Hospital das Clínicas, the patient\'s pupils became bilaterally dilated, and he lost brainstem reflexes in the absence of sedation, a clinical finding compatible with brain death. An apnea test was performed while the patient was normothermic with a mean arterial blood pressure of 86 mmHg by setting the ECMO to provide a pulse oximetry of at least 90% with the lowest sweeper flow setting. Mechanical ventilation was withdrawn, and continuous oxygen was supplied through the tracheal tube to prevent hypoxia. Close monitoring for respiratory movements was performed for 10 minutes. An arterial blood analysis was performed before and after the test to detect an increase in PaCO~2~ ([Table 2](#t2-cln_67p1511){ref-type="table"}). The neurological tests were repeated six hours later according to the Brazilian laws regulating the diagnosis of brain death. Transcranial Doppler ultrasonography indicated cerebral circulatory arrest, and computed tomography showed diffuse brain edema, brainstem herniation, and multiple foci of hemorrhage ([Figure 2](#f2-cln_67p1511){ref-type="fig"}). Thus, ICU support was withdrawn.

CASE DESCRIPTION 2
==================

A 42-year-old female with a previous history of illicit drug use was admitted to a tertiary hospital in Guarulhos, São Paulo, at 10 days postpartum with the diagnosis of community-acquired pneumonia. Five days later, she developed respiratory failure requiring mechanical ventilation and was transferred to the ICU. Two days later, her respiratory status deteriorated, with persistent hypoxemic and hypercapnic respiratory failure, and the ECMO response team from Hospital das Clínicas was called.

The patient had a peripheral oxygen saturation of 80% and a PaCO~2~ of 80 mmHg without hemodynamic compromise. Mechanical ventilation was set at a PEEP of 10 cmH~2~O, an FiO~2~ of 1, and a peak pressure of 35 cmH~2~O. Venous-venous ECMO support was initiated. Her blood gas parameters improved after ECMO support, and the patient was transferred by helicopter. The entire process, from the initial call to arrival at Hospital das Clínicas, lasted four hours. The chest radiograph acquired in our hospital is shown in [Figure 1b](#f1-cln_67p1511){ref-type="fig"}.

During the first two days after cannulation, the patient was sedated with propofol and fentanyl, with a Sedation-Agitation Scale ranging from 2 to 5 due to drug abstinence. Ventilation was set in pressure support mode with a positive-end expiratory pressure of 10 cmH~2~O, a pressure support of 8 cmH~2~O, and an FiO~2~ of 0.3. The ECMO settings were adjusted to achieve a PaO~2~\>50 mmHg.

The patient improved gradually ([Table 3](#t3-cln_67p1511){ref-type="table"}), and after seven days of extracorporeal support, she was awake and cooperative. Daily weaning tests from ECMO support were conducted in accordance with our criteria for ECMO discontinuation. ECMO was stopped nine days after initiation. Mechanical ventilation was discontinued two days later. The patient was discharged from the hospital 33 days after admission with no functional disability.

DISCUSSION
==========

The use of ECMO in adult patients has increased after the influenza A H1N1 outbreak. During the H1N1 epidemics, two observational studies reported a mortality rate of 20% with ECMO support compared to the expected 50% mortality in conventionally supported patients ([@b3-cln_67p1511],[@b4-cln_67p1511]). Additionally, in patients with severe lung injury, the CESAR trial showed that 63% of patients supported with an ECMO-including strategy survived without disability for six months compared to 47% of those allocated to conventional support ([@b1-cln_67p1511]).

Patient transfer
----------------

Most studies involving transfer to referral centers during ECMO opted to transfer the patient in conventional mechanical ventilation before starting ECMO support ([@b1-cln_67p1511],[@b3-cln_67p1511]). However, this type of transferinvolves considerable risk, and deaths have been described during the process ([@b1-cln_67p1511]). Conversely, previously published data show the safety and feasibility of the inter-hospital transport of critically ill adults under ECMO support ([@b5-cln_67p1511],[@b6-cln_67p1511]). After implementing a protocol for the safe transport of adults on ECMO, Forrest et al. described the transportation of 40 patients without deaths or major morbidity ([@b6-cln_67p1511]). In another study, transportation under ECMO support was associated with fewer episodes of hypoxia compared to patients transported under conventional ventilation ([@b7-cln_67p1511]). In both of our cases, we chose to initiate ECMO support before patient transfer to assure safer transport. There were no adverse events during transportation between the hospitals.

The optimal timing for ECMO initiation is not well established. Both of the patients described in this report were transferred from the same hospital in the city of Guarulhos. In the first case, ECMO was started several days after intubation, while the second patient was cannulated early after the diagnosis of severe respiratory failure. Because there is no organized referral system between our services, it is reasonable to presume that the first successful transport may have encouraged faster contact for the second patient. As previously reported by Forrest et al. ([@b6-cln_67p1511]), we believe that the development of a referral and transfer program is associated with faster ECMO initiation, safer transportation and, possibly, a higher rate of survival.

We propose the algorithm described in [Figure 3](#f3-cln_67p1511){ref-type="fig"} to create a transfer program for ECMO patients. As described in this report, earlier ECMO initiation is most likely associated with higher rates of survival. Therefore, we believe that a low threshold of hypoxemia despite optimal therapy should be sufficient to trigger an ECMO specialist consultation. The classical criteria for ECMO initiation should not be used as a trigger for consultation because it may adversely hinder support. In the presence of critical but reversible lung injury with no contraindication for extracorporeal support, an ECMO team (composed of two physicians and one registered nurse) would be responsible for the evaluation of the patient on location and, if indicated, ECMO support initiation. Because ECMO is a highly complex technique that involves high costs, constant personnel training and high complication rates ([@b8-cln_67p1511]), referral centers should be reserved for tertiary care centers only.

Brain death diagnosis during ECMO support
-----------------------------------------

Neurological injury is common in ECMO-supported patients. It is uncertain whether the extracorporeal support may precipitate injury or if the patient\'s morbid condition is the only responsible factor ([@b9-cln_67p1511]). A study of 295 patients from the ELSO registry for whom ECMO was used to support cardiopulmonary resuscitation reported brain death in 28% of non-survivors ([@b10-cln_67p1511]) More recently, ECMO support to maintain potential organ donors has been used to increase the donor pool ([@b11-cln_67p1511]).

Performing an apnea test in ECMO-supported patients is a major challenge because ECMO support is able to maintain normal blood gases in apneic patients. In case 1, we decided to disconnect the patient from the ventilator and then set the sweeper flow to the lowest level necessary to achieve a pulse oximetry of 90%. Respiratory movements were monitored, and blood gas analyses were obtained before and 10 minutes after a stable sweeper flow was initiated to detect an increase in the carbon dioxide partial pressure. Muralidharan et al. ([@b12-cln_67p1511]) reported three cases of possible brain death in ECMO patients in which the apnea test was not performed due to the lack of standardized procedures. However, they suggested that patients should remain connected to the ventilator under continuous positive airway pressure with a PaCO~2~ between 35--45 mmHg. Subsequently, they suggested that the sweeper flow be set to the minimum value compatible with normal pulse oximetry before the test. We adopted a similar procedure.

ECMO is a specialized technique and a lifesaving measure when other rescue therapies have failed. The treatment of patients under ECMO support must be performed in referral centers with a trained ECMO team. The transfer of patients seems plausible and safe. Despite recent advances and continuous training, there are still many uncertainties in the management of this specific population.
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###### 

Clinical data and arterial blood gases (Case 1).

  Data                                                                                                  Pre-ECMO                                          Day 1                                             Day 2                                             Day 3
  ----------------------------------------------------------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- -------------------------------------------------
  **Mechanical ventilation**                                                                                                                                                                                                                                  
      Ventilatory mode                                                                                  PCV[I](#tfn5-cln_67p1511){ref-type="table-fn"})   PCV[I](#tfn5-cln_67p1511){ref-type="table-fn"})   PCV[I](#tfn5-cln_67p1511){ref-type="table-fn"})   PCV[I](#tfn5-cln_67p1511){ref-type="table-fn"})
      Peak pressure (min--max) - cmH~2~O                                                                                                                  25                                                22                                                24
      PEEP (min--max) -                                                                                                                                   12                                                10                                                10
      cmH~2~O [£](#tfn6-cln_67p1511){ref-type="table-fn"})                                                                                                0.5                                               0.5                                               0.6
      FIO~2~ (minmax) [¥](#tfn7-cln_67p1511){ref-type="table-fn"})                                                                                        20--54                                            20-22                                             20-24
      Respiratory rate (min--max) - breaths/min **ECMO** [J](#tfn8-cln_67p1511){ref-type="table-fn"})                                                     3.3--6.4                                          4.49-4.79                                         4.58-7.9
      Blood flow (min--max) - L/min                                                                                                                       10                                                6-10                                              8
      Sweeper flow (min--max) - L/min                                                                                                                     1.0                                               1.0                                               1.0
      FIO~2~                                                                                                                                                                                                                                                  
  **Routine blood gas**                                                                                                                                   48.5                                              44.8                                              57
      PaO~2~ - mmHg                                                                                                                                       40.3                                              44.3                                              22.6
      PaCO~2~ - mmHg                                                                                                                                      8.4                                               -6.5                                              -13.3
      SBE - mEq/L [\*](#tfn1-cln_67p1511){ref-type="table-fn"})                                                                                           7.51                                              7.27                                              7.30
      pH                                                                                                                                                                                                                                                      
  **Patient data**                                                                                                                                        1                                                 1                                                 1
      SAS (min--max)[\#](#tfn2-cln_67p1511){ref-type="table-fn"})                                                                                         2.75                                              2.5                                               2.5
      Lung injury score [\"](#tfn4-cln_67p1511){ref-type="table-fn"})                                                                                     8                                                 18                                                19
      Total SOFA score [1](#tfn3-cln_67p1511){ref-type="table-fn"})                                                                                       4                                                 4                                                 4
      Respiratory SOFA                                                                                                                                    0                                                 4                                                 2
      Cardiovascular SOFA                                                                                                                                 0                                                 0                                                 3
      Hematological SOFA                                                                                                                                  2                                                 2                                                 2
      Hepatic SOFA                                                                                                                                        2                                                 4                                                 4
      Neurological SOFA                                                                                                                                   0                                                 4                                                 4
      Renal SOFA                                                                                                                                                                                                                                              

SBE denotes standard base excess.

SAS denotes the Sedation-Agitation Scale.

SOFA denotes sequential organ failure assessment. This score is used to diagnose and quantify organ failure, and it ranges from 0 to 24.

The lung injury score is Murray\'s score, which quantifies the severity of lung injury based on the respiratory compliance, PEEP, number of quadrants infiltrated on a chest X-ray and PaO~2~/FIO~2~ ratio.

PCV denotes pressure-controlled ventilation.

PEEP denotes positive end-expiratory pressure.

FiO~2~ denotes the inspiratory fraction of oxygen.

ECMO denotes extracorporeal membrane oxygenation.

###### 

Arterial blood gases during the apnea test in patient 1.

                                                         1° test       2° test                     
  ------------------------------------------------------ ------------- ------------- ------------- -------------
  **pH**                                                 7.303         7.072         7.319         7.141
  **PaO~2~**                                             67.0 mmHg     61.2 mmHg     100.3 mmHg    66.3 mm Hg
  **PaCO~2~**                                            50.3 mmHg     87.3 mmHg     44.4 mmHg     73.0 mm Hg
  **Saturation**                                         90.5%         77.1%         97.0%         84.2%
  **Bicarbonate**                                        24.3 mmol/L   24.9 mmol/L   22.3 mmol/L   24.3 mmol/L
  **SBE**[\*](#tfn9-cln_67p1511){ref-type="table-fn"})   -2.6 mmol/L   -7.5 mmol/L   -3.9 mmol/L   -6.3 mmol/L
  **Lactate**                                            21 mg/dL      24 mg/dL      25 mg/dL      24 mg/dL

SBE denotes standard base excess.

###### 

Clinical data and arterial blood gases (Case 2).

  Data                                                                                                   Pre-ECMO                                           Day 1                                              Day 2                                              Day 5                                              Day 10
  ------------------------------------------------------------------------------------------------------ -------------------------------------------------- -------------------------------------------------- -------------------------------------------------- -------------------------------------------------- --------------------------------------------------
  **Mechanical ventilation**                                                                                                                                                                                                                                                                                         
      Ventilatory mode                                                                                   PCV[I](#tfn14-cln_67p1511){ref-type="table-fn"})   PCV[I](#tfn14-cln_67p1511){ref-type="table-fn"})   PCV[I](#tfn14-cln_67p1511){ref-type="table-fn"})   PSV[2](#tfn15-cln_67p1511){ref-type="table-fn"})   PSV[2](#tfn15-cln_67p1511){ref-type="table-fn"})
      Peak pressure (min--max) - cmH2O                                                                                                                      25                                                 2515                                               2515                                               2013
      PEEP (min--max) - cmH2O [£](#tfn16-cln_67p1511){ref-type="table-fn"})                                                                                 0.6                                                0.3                                                0.3                                                0.6
      FIO2 (min--max) [¥](#tfn17-cln_67p1511){ref-type="table-fn"})                                                                                         15-21                                              19-28                                              16-36                                              14-42
      Respiratory rate (min--max) - breaths/min **ECMO** [J](#tfn18-cln_67p1511){ref-type="table-fn"})                                                      3.02-                                              4.48-6.62                                          4.05-                                              3.67-
      Blood flow (min--max) - L/min                                                                                                                         5.33                                               6                                                  5.08                                               3.84
      Sweeper flow (min--max) - L/min                                                                                                                       6--7                                               1.0                                                3-4.5                                              0.5
      FIO~2~                                                                                                                                                1.0                                                                                                   1.0                                                1.0
  **Routine blood gas**                                                                                                                                                                                        66.3                                                                                                  
      PaO~2~ - mmHg                                                                                                                                         51.4                                               42.4                                               52                                                 79.8
      PaCO~2~ - mmHg                                                                                                                                        40.6                                               +1.9                                               33                                                 57.3
      SBE - mEq/L [\*](#tfn10-cln_67p1511){ref-type="table-fn"})                                                                                            -0.6                                               7.41                                               +6.1                                               +6.6
      pH                                                                                                                                                    7.39                                                                                                  7.41                                               7.38
  **Patient data**                                                                                                                                                                                             2--6                                                                                                  
      SAS (min -- max)[\#](#tfn11-cln_67p1511){ref-type="table-fn"})                                                                                        2                                                  2.5                                                3-5                                                4
      Lung injury score [\"](#tfn13-cln_67p1511){ref-type="table-fn"})                                                                                      3                                                  6                                                  2.75                                               2.5
      Total SOFA score [1](#tfn12-cln_67p1511){ref-type="table-fn"})                                                                                        6                                                  4                                                  8                                                  4
      Respiratory SOFA                                                                                                                                      4                                                  0                                                  4                                                  4
      Cardiovascular SOFA                                                                                                                                   0                                                  0                                                  2                                                  0
      Hematological SOFA                                                                                                                                    0                                                  0                                                  0                                                  0
      Hepatic SOFA                                                                                                                                          0                                                  2                                                  0                                                  0
      Neurological SOFA                                                                                                                                     2                                                  0                                                  2                                                  0
      Renal SOFA                                                                                                                                            0                                                                                                     0                                                  0

SBE denotes standard base excess.

SAS denotes the Sedation-Agitation Scale.

SOFA denotes sequential organ failure assessment. This score is used to diagnose and quantify organ failure, and it ranges from 0 to 24.

The lung injury score is Murray\'s score, which quantifies the severity of lung injury based on the respiratory compliance, PEEP, number of quadrants infiltrated on a chest X-ray and PaO2/FIO2 ratio.

PCV denotes pressure-controlled ventilation.

PSV denotes pressure-support ventilation

PEEP denotes positive end-expiratory pressure.

FiO2 denotes the inspiratory fraction of oxygen.

ECMO denotes extracorporeal membrane oxygenation.
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